abrdn Life Sciences Investors
 
 
 
 
基本資料
種類: ETF
費用比率%: 1.24
資產淨值: 18.78
成立日期: 08/05/1992
 
分析
市值分佈:
41.92%
大市值
28.32%
中市值
18.25%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 21/02/2026 06:08) 總持有投資項目: 78  
0%
 
100%
     10大 (28.22%)
代號 名稱 佔比% 持有日期
AMGNAmgen3.6231/01/2026
PCVXVaxcyte3.3131/01/2026
INSMInsmed Incorporated2.9231/01/2026
QUREuniQure NV2.8231/01/2026
REGNRegeneron Pharmaceuticals2.7831/01/2026
CRNXCrinetics Pharmaceuticals2.7831/01/2026
DNLIDenali Therapeutics2.6831/01/2026
FULCFulcrum Therapeutics2.6231/01/2026
ARGXargenx SE2.4231/01/2026
PSNLPersonalis2.2631/01/2026
DYNDyne Therapeutics2.2131/01/2026
RAREUltragenyx Pharmaceutical2.1431/01/2026
IMVTImmunovant2.0531/01/2026
XENEXenon Pharmaceuticals1.9531/01/2026
EWTXEdgewise Therapeutics1.8731/01/2026
VRTXVertex Pharmaceuticals1.8031/01/2026
ALNYAlnylam Pharmaceuticals1.7331/01/2026
CYTKCytokinetics1.6931/01/2026
ARWRArrowhead Pharmaceuticals1.6531/01/2026
SRPTSarepta Therapeutics1.5131/01/2026
 1    2    3    4  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.